SAN FRANCISCO (MarketWatch) — Immucor Inc.
agreed to buy BioArray Solutions Ltd., a privately held Warren, N.J., maker of transfusion genotyping systems, for about $117 million. Immucor, a Norcross, Ga., seller of reagents and systems used for blood typing, expects the deal to reduce per-share earnings for “several years” following closing. In the first full year of ownership, Immucor expects the acquisition to cut earnings by 20 cents to 23 cents a share. Current BioArray equity holders will form a new company before the deal closes to commercialize BioArray technologies in fields outside blood transfusion and transplantation. Immucor will receive a 19% stake in the new company.
View more information: https://www.marketwatch.com/story/immucor-to-acquire-bioarray-solutions-ltd-for-117m